首页 > 资讯
FUKUOKA, Japan, Oct. 17, 2024 (GLOBE NEWSWIRE) - Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Life Whisperer, a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF patients.
Life Whisperer comprises three AI algorithms. Life Whisperer Viability assesses images of embryos to determine the likelihood that the embryo will lead to a pregnancy. Life Whisperer Genetics evaluates an embryo's morphological quality and its likelihood of being genetically normal (euploid). Life Whisperer Oocyte evaluates images of oocytes (single or group culture) to determine how likely the oocytes are to form a good quality embryo, or blastocyst. Multiple international studies have shown Life Whisperer can improve pregnancy and live birth outcomes.
The acquisition by Astec, with their strong global distribution network in the fertility sector, will accelerate the proliferation of this promising AI technology into IVF labs around the world. Astec also intends to make Life Whisperer a key feature of its embryo incubator product range.
Takeo Cho, Deputy CEO of Astec said “We are excited to incorporate Life Whisperer in our product range to further our mission of supporting the assisted reproductive industry globally. We believe AI will be a core feature of every IVF lab in the future and we are delighted to offer our customers one of the most advanced and validated products in the market.”
Astec is already offering Life Whisperer to its customers in Japan and Indonesia and will commence its global rollout to make Life Whisperer available in other countries.
Life Whisperer
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo and Life Whisperer Oocyte assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
For any queries regarding Life Whisperer and Astec products, please contact: narita@astec-bio.com
相关推荐
- NTT DATA Celebrated as a Global Top Employer 2025 in 33 Countries/Regions
- Tecnotree在2024年Gartner®通信行业客户体验和货币化技术成熟度曲线(Hype Cycle™)中得到认可
- 年货进京1号线 有“蛇”有得新年见——热烈庆祝天津市昽森农业科技有限公司入选北京地铁1号线年货进京武清专列
- Cyble在《2025年第一季度扩展威胁情报服务提供商格局》中获得认可
- 南通移动携手华为完成400G OTN试点测试,引领绿色通信新发展
- 欧洲智慧能源展:双向充电可节省数十亿美元
- Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 搜索
-
- 01-16NTT DATA Celebrated as a Global Top Employer 2025 in 33 Countries/Regions
- 01-16Tecnotree在2024年Gartner®通信行业客户体验和货币化技术成熟度曲线(Hype Cycle™)中得到认可
- 01-16年货进京1号线 有“蛇”有得新年见——热烈庆祝天津市昽森农业科技有限公司入选北京地铁1号线年货进京武清专列
- 01-16Cyble在《2025年第一季度扩展威胁情报服务提供商格局》中获得认可
- 01-16南通移动携手华为完成400G OTN试点测试,引领绿色通信新发展
- 01-16欧洲智慧能源展:双向充电可节省数十亿美元
- 01-16Diligent宣布推出由S&P Global市场情报部门提供支持的Market Insights Reporting,为董事和高管提供无与伦比的财务和风险洞察
- 01-16戴尔科技 x 赛轮集团:打造橡胶行业首个工业互联网平台
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 01-16世贸通美国EB5投资移民: I-956F拒签率近16%,这个局怎么破?
- 标签列表